Ludwig Fendt
Co-Founder & CEO
This company provides an IoT and AI platform for hospitals that automates bedside patient monitoring and nursing tasks using proprietary medical devices. The platform integrates real-time data with hospital information systems via HL7/FHIR interfaces for comprehensive analysis. This solution enhances patient safety through early complication detection and improves clinical workflows by providing data-driven decision support.
Raised to date
$1.5MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Manual urine catheter monitoring is time-intensive, prone to errors, and can lead to delayed detection of critical complications such as acute kidney injury (AKI) and sepsis. The traditional process requires significant nursing time for measurement, documentation, and fluid balance calculation, diverting resources from direct patient care.
Elixion provides an automated urine catheter monitoring system leveraging medical IoT and AI to deliver real-time urine flow data and early detection of complications. The system consists of a wireless, reusable device compatible with standard urine bags and urometer systems that automatically measures and documents urine output with improved accuracy. Data is transmitted wirelessly and integrated into hospital information systems via HL7/FHIR interfaces. The system analyzes real-time data to provide notifications of abnormal urine flow, facilitating earlier intervention and improved patient outcomes.
The primary target audience includes nurses, physicians, and hospital management seeking to reduce workload, improve patient outcomes, and enhance cost efficiency in patient monitoring.